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Objective: To investigate the predictive value of functional impairment, chronic conditions, and 
laboratory biomarkers of aging for predicting 5-year mortality in the elderly aged 85 years.
Methods: Predictive value for mortality of different geriatric assessments carried out during 
the OCTABAIX study was evaluated after 5 years of follow-up in 328 subjects aged 85 years. 
Measurements included assessment of functional status comorbidity, along with laboratory tests 
on vitamin D, cholesterol, CD4/CD8 ratio, hemoglobin, and serum thyrotropin.
Results: Overall, the mortality rate after 5 years of follow-up was 42.07%. Bivariate analysis 
showed that patients who survived were predominantly female (P=0.02), and they showed a sig-
nificantly better baseline functional status for both basic (P,0.001) and instrumental (P,0.001) 
activities of daily living (Barthel and Lawton index), better cognitive performance (Spanish 
version of the Mini-Mental State Examination) (P,0.001), lower comorbidity conditions 
(Charlson) (P,0.001), lower nutritional risk (Mini Nutritional Assessment) (P,0.001), lower 
risk of falls (Tinetti gait scale) (P,0.001), less percentage of heart failure (P=0.03) and chronic 
obstructive pulmonary disease (P=0.03), and took less chronic prescription drugs (P=0.002) 
than nonsurvivors. Multivariate Cox regression analysis identified a decreased score in the 
Lawton index (hazard ratio 0.86, 95% confidence interval: 0.78–0.91) and higher comorbidity 
conditions (hazard ratio 1.20, 95% confidence interval: 1.08–1.33) as independent predictors 
of mortality at 5 years in the studied population.
Conclusion: The ability to perform instrumental activities of daily living and the global 
comorbidity assessed at baseline were the predictors of death, identified in our 85-year-old 
community-dwelling subjects after 5 years of follow-up.
Keywords: oldest old, mortality, comorbidity, instrumental activity of daily living
Introduction
Despite the increasing number of oldest old population worldwide, longitudinal studies 
specifically designed to assess mortality in subjects aged over 85 years (the current 
fastest growing population subgroup in many countries) are still scarce in medical 
literature.1–3
The ability to predict mortality by measuring functional status, on contrary to 
chronic conditions or usual laboratory tests, may increase as age increases.4 In younger 
subjects, aged 65 years or less, chronic conditions have been reported to predict 
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mortality better rather than functional limitations, which 
were stronger predictors of death in people aged 90 years.5,6 
However, elderly subjects aged 85 years are frequently 
unable to perform functional tests; thus, it has been suggested 
that the assessment of activities of daily living (ADL), rather 
than chronic conditions or laboratory biomarkers, may be 
a useful tool for short- and long-term prognostication of 
survival in such oldest old people.1
Predictive properties of chronic conditions, functional 
limitations, and several laboratory tests used as prognostic 
markers of survival in the oldest old community residents 
have been addressed separately in previously published 
studies. In the present study, our aim was to evaluate the 
predictive value of 5-year mortality by looking at different 
characteristics included in the geriatric assessment and by 
analyzing laboratory data carried out on 328 community 
residents included in the OCTABAIX study, aged 85 years 
at baseline. The global assessments included evaluation of 
functional and cognitive status, comorbidity, nutritional 
and falls risk, quality of life, social risk, long-term drug 
prescription, and laboratory analysis (including vitamin D, 




As described elsewhere, the OCTABAIX study was a 
cohort study that included a randomized controlled trial, 
undertaken with a primary purpose of falls and malnutrition 
prevention by intervention in 85-year-old subjects from the 
community.1,7 All community-dwelling inhabitants born in 
1924 and registered at one of the seven primary health care 
centers in Baix Llobregat in Barcelona, Spain, were con-
tacted. The combined population served by these health care 
teams includes ~210,000 inhabitants out of a total of 800,000 
inhabitants in Baix Llobregat. The seven voluntary health 
care centers involved in other elderly assessments were of the 
same geographical area and had similar data regarding immi-
gration percentage (11%) or population served. The study 
was double-blinded, and included 328 noninstitutionalized 
subjects. No criteria related to baseline health or cognitive 
status was applied to exclude patients. The only exclusion 
critera was to be institutionalized. There were no differences 
among respondents and nonresponders for the participation 
contact in terms of sex, health care center, or physician in 
charge. The institutional ethics committee of Fundació Gol i 
Gorina approved the design of the study and all patients – or 
the caregivers for those cognitively impaired subjects gave 
their written informed consent before enrollment. After 
recruitment, all subjects and caregivers were interviewed at 
their home or health care center by a nurse or a physician of 
the research team, all of them trained in geriatric care. The 
intervention consisted in providing exercise and nutritional 
recommendations to the subject and caregiver, as well as 
their primary care physician, for reducing the incidence of 
falls and the risk of undernutrition in this population. Control 
subjects only received a general primary care assessment. 
All participants were followed for a 3-year period, and 
received during the follow-up period two in-home visits 
from a member of the research team, who assessed falls 
and nutritional risk factors as primary outcome by using an 
algorithm. Secondary outcomes included a wide range of 
different geriatric characteristics. Sociodemographic data 
(sex, marital status, place of residence, studies, and living 
alone), comorbidity, and a comprehensive geriatric evalua-
tion (functional, cognitive and nutritional status, social risk, 
gait, and risk of falls) were used for this evaluation.
Present study
On the basis of the OCTABAIX study, the present investi-
gation evaluated the usefulness to predict mortality of the 
geriatric assessment carried out 5 years before, based on tools 
that are currently used in geriatric practice. Furthermore, we 
assessed if these results were modified by including laboratory 
tests, such as vitamin D levels, cholesterol, CD4/CD8 ratio, 
hemoglobin, and serum thyrotropin, of which may be associ-
ated with a higher risk of mortality in an older population.
geriatric assessment at baseline
Functional status was measured using the Barthel index (BI)8 
for basic ADL and the Lawton index9 (LI) for instrumental 
ADL. BI measures include questions about seven areas: 
feeding, bathing, personal hygiene, dressing, bowel/bladder 
control, getting on/off the toilet, and locomotion. A maximum 
score of 100 indicates that the subject is independent in 
physical function and the lowest score of 0 indicates a totally 
dependent state. The LI is an easy to administer assessment 
instrument that provides self-reported information about 
functional skills necessary to live in the community. LI score 
ranges from 0 (low function, dependent) to 8 (high function, 
independent). Historically, female were scored on all eight 
areas of function; males were not scored in the domains of 
food preparation, housekeeping, and laundering. However, 
we applied the current recommendations to assess all domains 
for both sexes.10 A limitation of the instrument includes the 
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Predictors of 5-year mortality in the oldest old
than a demonstration of the functional task. Cognitive func-
tion was measured by the Spanish version of the Mini-Mental 
State Examination (MEC), which has a total score of 35. As 
recommended, we considered MEC scores 23 to indicate 
the presence of cognitive impairment.11 Nutritional status was 
assessed using the Mini Nutritional Assessment (MNA).12 The 
MNA score is based on 18 items covering four component 
subscores. The MNA score obtained (maximum 30 points) 
classifies the assessed subjects into three categories: 24–30, 
well-nourished; 17–23.5, at risk of malnutrition; and ,17, 
malnourished. Gait was evaluated with the gait rating scale 
from the Tinetti Performance-Oriented Mobility Assessment 
that provides a final score, which ranges from 0 to 12, with 
a higher score indicating better gait performance.13 Patients 
and/or caregivers were asked about the number of falls in the 
last year. The Gijon scale was used for the social assessment.14 
This scale is scored on a maximum of 24 points. Social risk 
scores are those between 10 and 14 and social problems 
exist with scores .15. Quality of life was assessed using the 
visual analogue scale of the quality of life test (EQ-VAS) of 
perceived health.15 The EQ-VAS records the respondent’s 
self-rated health on a 20 cm vertical, visual analogue scale 
with endpoints labeled “the best health you can imagine” 
(100) and “the worst health you can imagine” (0).
Comorbidity assessment
The Charlson score (CS) was used to measure overall 
comorbidity.16 It ranges from 0 to a theoretical maximum 
of 33, depending on the presence of certain diseases with 
assigned values. Age-adjusted CS was not used since all 
participants were 85 year olds. Cardiovascular risk factors 
such as high blood pressure, diabetes mellitus, and dyslipi-
demia were also recorded. Disease prevalence for ischemic 
cardiopathy, heart failure, chronic obstructive pulmonary 
disease (COPD), stroke, and dementia was determined on 
the basis of a data review from general practice records. 
The number of drugs used by prescription on a chronic basis 
was also recorded. In most cases, the physician who obtained 
the information was at the same time the one who usually 
cared for the patient, comorbidity data was therefore, not 
only derived from self-reports but also from chart reviews, 
test results, and prescription drug indications.
laboratory measurements
Blood samples were drawn between 9 and 10 am. Hemoglobin, 
total leukocytes, and lymphocytes were measured on an 
automated counter. The World Health Organization’s definition 
of anemia defines this entity as a hemoglobin concentration 
below 12 g/dL in female and 13 g/dL in males and was used 
to determine the presence of anemia. T-lymphocyte subsets 
were determined by flow cytometry. Aliquots from peripheral 
blood samples were stained with the following fluorochrome-
conjugated monoclonal antibodies in double combinations: 
anti-CD3-FITC (clone SK7)/anti-CD4-PE (clone SK3) and 
CD3-FITC (clone SK7)/anti-CD8-PE (clone SK1) were 
purchased from Becton Dickinson (San Jose, CA, USA). 
A minimum of 2,000 events per sample were acquired on a 
FACScalibur flow cytometer (Becton Dickinson). Forward 
light scatter and side light scatter parameters were used to gate 
viable lymphocytes. These gated lymphocytes were then ana-
lyzed by two-color immunofluorescence with CellQuest soft-
ware (Becton Dickinson). A CD4:CD8 ratio (numbers of CD4 
and CD8 cells) of 1.00 was used to identify individuals with a 
possible immune risk phenotype. The use of CD4 and CD8 per-
centages resulted in identical CD4:CD8 ratio categorization.17 
Total cholesterol (CHOD-PAP, Roche Diagnostics, Basel, 
Switzerland) and serum HDL-C concentrations (HDL-C Plus, 
Roche Diagnostics) were measured by a direct enzymatic colo-
rimetric method. Serum LDL-C concentrations were calculated 
using the Friedewald equation. The interassay coefficient of 
variation for HDL-C was ,5.0%. All procedures were carried 
out with a modular system analyzer (Roche Diagnostics).18 
Serum levels of 25(OH)D (25-hydroxyvitamin D) (radioimmu-
noanalyses, DiaSorin, Stillwater, MN, USA) were considered 
normal between 25 and 95 ng/mL.19 The detection limit of 
serum 25(OH)D was 5 nmol/L, the intraassay coefficient of 
variation was 5.6%, and the interassay coefficient was 9.2%. 
Serum 25(OH)D concentrations were used to assess vitamin D 
status. Hypovitaminosis D was considered as ,25 ng/mL 
and deficiency ,11 ng/mL. Plasma concentrations of thy-
rotropin (TSH) and free thyroxine (FT4) were measured 
using an electrochemiluminescence immunoassay based on 
the sandwich principle with monoclonal antibodies (Roche 
Diagnostics).20 The reference range was 0.25–5.0 mU/L for 
TSH and 10–26 pmol/L for FT4. Interassay coefficients of 
variation were 1.96%–3.56% for TSH and 1.91–3.68 for FT4. 
All laboratory measurements were carried out in the primary 
care Laboratori Clínic L’Hospitalet, while T-lymphocytes 
subsets and serum 25(OH)D concentrations were processed 
in the referral Laboratori Clínic of the Hospital Universitari de 
Bellvitge (Immunology and Biochemistry Services).
Outcome events
Mortality, measured as time-to-event data, was the main 
outcome of the present study. For that purpose, the vital 
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5 years of follow-up. Subjects were categorized as alive 
after 60 months of follow-up, or censored when they died, 
whichever occurred first. Mortality status and causes were 
determined by trained physician adjudicators on the basis 
of medical records from hospitalizations, emergency room 
visits, death certificates, and autopsy and coroner’s reports, 
when available. There was no loss of follow-up. Patients who 
survived were compared with those deceased.
statistical analysis
Normally distributed continuous variables are reported as 
mean ± standard deviation (SD). Categorical variables are 
reported as proportions. The Student’s t-test was used to 
compare continuous variables, with a previous Levene test 
for equality of variances, while either the chi-square statistic 
or Fisher’s exact test was used to compare categorical or 
dichotomous variables. Cox models were adjusted between 
main outcome variables and predictors. The semiparametric 
Cox proportional hazards model analyses the relationship 
between a time-to-event response variable and adjusted 
baseline covariates. Proportional hazards and linearity (on 
continuous variables) assumptions were evaluated for the 
Cox models to determine the variables associated with 
5-year mortality.
The variables entered into the model using a backward-
stepwise approach were sex and all the geriatric and global 
comorbidity (not simple diseases as heart failure or COPD) 
variables with significant differences in the bivariate analy-
sis, such as the BI, LI, MEC, Charlson comorbidity index, 
MNA, Tinetti gait scale, and chronic drugs prescription. The 
significance level was fixed at 5%. Since this is mainly an 
exploratory analysis and covariates associated with the main 
outcome variable are unknown or not fully understood, we 
performed an algorithm variable selection based solely on 
backward-stepwise approach. The variable selection process 
was supervised by clinical criterion in order to ensure the 
result’s reliability and meaningfulness. We repeated the model 
five times adding values of lipid profile (cholesterol total, 
HDL-C, and LDL-C), or adding vitamin D, hemoglobin, CD4/
CD8 ratio, or serum thyrotropin, and the results did not change. 
An adjusted hazard ratio (HR) with a 95% confidence interval 
(CI) was used. The results were considered significant when 
P,0.05. All analyses were performed using SPSS version 
15.0 statistical software (SPSS Inc., Chicago, IL, USA).
Results
At baseline, the sample included 328 community-dwelling 
subjects aged 85 years, 202 (61.6%) of them were female. 
Geriatric assessment tools, cardiovascular risk factors, and 
comorbidity conditions are shown in Table 1. Table 2 shows 
the results of the laboratory analysis, which included hemo-
globin, CD4/CD8 ratio, vitamin D, cholesterol profile, and 
serum thyrotropin.
evaluation after 5-year follow-up
Of the total 328 participants, 138 (42.07%)  died during the 
5-year follow-up period; and of these, 75 (45.7%) belonged 
to the control group, those who only received a general 
primary care assessment, and 63 (38.4%) to the interven-
tion group (P=0.18). The annual average mortality rate was 
8.4% which was distributed as follows: 4.9% within the 
first year, 5.8% in the second, 6.7% in the third, 10.6% in 
the fourth, and 14% during the fifth year of follow-up. The 
comparison of death distribution by sex showed statistical 
significant differences: 75 (37.1%) females died out of the 
total 202, compared with 63 (50%) males who died out of 
the total 126 (P=0.02).
Predictors of mortality
The bivariate analysis of baseline variables associated with 
5-year survival is shown in Table 1. Patients who survived 
were predominantly female and had a significantly better 
baseline functional status for both basic and instrumental 
ADL, better cognitive performance, lower comorbidity, 
lower nutritional risk, lower risk of falls, less percent-
age of heart failure and COPD, and they were taking less 
chronic prescription drugs. Table 2 shows laboratory test 
values associated with 5-year mortality compared between 
survivors and nonsurvivors. Among those variables that 
were significant at the bivariate level; multivariate Cox 
regression analysis (Table 3) identified two clinical 
variables that maintained significance – LI and Charlson 
comorbidity indexes – as independent predictors of 5-year 
risk of mortality in our cohort of elderly community 
residents aged 85 years at baseline. The addition to the 
Cox model of the serum values of hemoglobin, CD4:CD8 
ratio, vitamin D, and cholesterol levels did not modify the 
value of the previously selected LI and Charlson index 
variables for predicting 5-year mortality, in the cohort 
of oldest old community-dwelling participants from the 
OCTABAIX study.
Discussion
According to the present study, functional declining and global 
comorbidity are the strongest predictors for 5-year mortal-
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Predictors of 5-year mortality in the oldest old


















































living alone 100 (30.5%) 65 (34.2%) 25 (25.4%) 0.08
Barthel index 87.6±19 91.6±12 81.9±24 0.0001
Barthel index .90 197 (60%) 129 (67.8%) 68 (49.2%) 0.001
MeC 26.7±6.8 27.8±5.8 25.6±7.7 0.001
MeC .23 90 (72.6%) 152 (80%) 86 (62.3%) 0.001
lawton IADl index 5.3±2.5 6.03±2.1 4.4±2.8 0.0001
gijon 9.8±2.6 9.6±2.5 10.1±2.7 0.18
eQ-VAs 62±21 63.9±19 59.5±22 0.06
Charlson index 1.4±1.6 1.09±1.2 1.9±1.8 0.0001
number of drugs taken 6±3 5.6±3.4 6.7±3.4 0.002
MnA-sF 24.5±3.7 25.1±3.5 23.7±3.7 0.0001
Tinetti 6.6±2.9 7.1±2.5 5.9±3.0 0.0001
hypertension 249 (75.9%) 149 (78.4%) 100 (72.5%) 0.21
Diabetes mellitus 58 (17.7%) 34 (17.9%) 24 (17.4%) 0.91
Dyslipidemia 168 (51.2%) 102 (53.7%) 66 (47.8%) 0.29
Medical history of stroke 49 (14.9%) 26 (13.7%) 23 (16.7% 0.45
Dementia 31 (9.5%) 9 (4.7%) 22 (15.9%) 0.76
Ischemic cardiopathy 20 (6.1%) 7 (3.7%) 13 (9.4%) 0.05
heart failure 42 (12.8%) 18 (9.5%) 24 (17.4%) 0.03
COPD 34 (10.4%) 14 (7.4%) 20 (14.5%) 0.03
Falls 0.40±0.9 0.44±0.9 0.38±1.1 0.58
Note: Data presented as mean ± standard deviation or n (%).
Abbreviations: COPD, chronic obstructive pulmonary disease; eQ-VAs, quality of life with the visual analogue scale; IADl, instrumental activities of daily life; MeC, spanish 
version of the Mini-Mental state examination; MnA-sF, Mini nutritional Assessment questionnaire (short form).








hemoglobin, mg/dl 13.2±1 13.3±1 13.1±2 0.34
Anemia 79 (24.1%) 38 (20%) 41 (29.7%) 0.04
leukocytes 6,757±1,882 6.659±2.032 6.948±2.032 0.17
lymphocytes 1,873±910 2,112±662 2,013±800 0.22
T-CD4 (n=312) 42.9±10 42.6±11 43.1±10 0.67
T-CD8 (n=312) 24.9±10 24.6±9 25.6±11 0.18
CD4:CD8 ratio (n=312) 2.2±1.5 2.28±1.4 2.11±1.6 0.24
25-hydroxyvitamin D, ng/ml (n=312) 28±30 28.4±28 27.2±33 0.73
Total cholesterol, mg/dl (n=321) 194±36 199±35 187±37 0.003
lDl cholesterol, mg/dl (n=321) 114±31 117±31 109.3±31 0.01
hDl cholesterol, mg/dl (n=321) 56.5±15 58.5±15 53.5±14 0.004
serum thyrotropin, mU/l (n=318) 2.7±2.6 2.7±2.9 2.6±2.1 0.609
Note: Data presented as mean ± standard deviation or n (%).
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at baseline, rather than the measurement of usual blood 
laboratory tests classically associated with death. Results 
reaffirmed the clinical prognostic properties of comprehen-
sive geriatric assessment in elderly community residents, in 
whom a better ability to perform instrumental ADL and the 
presence of a less number of comorbidity conditions, predict 
a chance for 5-year survival. In our population-based sample 
of community residents aged 85 years, we found a consider-
able mortality rate (42.07%) after a long-term follow-up of 
5 years. This finding was consistent with the 46% reported 
in the Leiden 85+ study (5-year follow-up)21 and the 47.6% 
reported in the Newcastle 85+ study (6-year follow-up),2 two 
recent reports of reference in a population aged 85 years or 
older. As would be expected according to these earlier studies, 
our results also showed that annual average mortality rates 
clearly grew throughout the 5 years of follow-up, and were 
in accordance with the results of a previous study we took in 
other sample of nonagenarian individuals, which showed a 
mortality rate of 75% after 5 years of follow-up.6
Chronic conditions have been reported to be more 
predictive of all-cause mortality among younger individu-
als (aged 50–60 years) than functional limitations, which 
have been more predictive of mortality among elderly 
subjects (aged 80–99 years).1 Interestingly, results from 
the Leiden 85+ study showed that instrumental ADL 
ability (assessed using the Groningen activity restriction 
scale) was associated with an increased risk of mortal-
ity after 2 and 12 years of follow-up (HR 6.11 and 2.75, 
respectively).2 Our results suggested that both functional 
status and chronic conditions measured at baseline were the 
strongest predictors for 5-year mortality in our OCTABAIX 
study cohort of elderly community-dwelling adults aged 
85 years. Furthermore, the extension from 3 to 5 years of 
follow-up in this cohort of subjects, clearly reaffirmed the 
previously documented prognostic properties of current 
geriatric assessment tools for predicting of living till 85- or 
90-years old. In this cohort the instrumental had a better 
discriminative ability than the basic ADL, may be partly due 
to the high proportion of individuals with normal or almost 
normal baseline BI values. This hierarchical relationship 
between basic and instrumental ADL comported that dis-
ability in instrumental ADL was a more sensitive predictor 
of functional decline.22
In this group of very old patients, it was not surprising 
to find that the association between global comorbidity 
(Charlson Index) and 5-year mortality was stronger than other 
common diseases or cardiovascular risk factors. Furthermore, 
none of the variables associated with lower 5-year mortality, 
which lost significance in the multivariate analysis, was also 
surprising. Patients aged 85 years at baseline who survived 
5 years of follow-up were predominantly female and they had 
significantly better baseline functional status for basic ADL, 
better cognitive performance, lower nutritional risk, lower 
risk of falls, less percentage of heart failure and COPD, and 
were taking less chronic prescription drugs, an item closely 
related to comorbidity.
A recently published Leiden 85+ study reported that 
the number of abnormalities in seven routine laboratory 
measurements predicts 5-year mortality as accurately as 
gait speed and instrumental ADL disability.21 When we 
evaluated blood laboratory tests that individually could be 
associated with increased risk of mortality, results found that 
anemia and low levels of total cholesterol, HDL cholesterol, 
and LDL cholesterol were associated with a higher risk of 
5-year mortality; while CD4/CD8 ratio, levels of vitamin D 
and thyroid hormone were not. When each of these vari-
ables were incorporated separately in the logistic regression 
model for 5-year mortality analysis, all of them resulted in 
changing the model, and reaffirmed the significance of the 
previously identified IL and Charlson index as the associated 
independent variables.
In accordance with the previous results of several 
published studies in persons aged 85 years, anemia 
increased mortality in these population, with a mortality HR 
reported of 1.41 for prevalent anemia and 2.08 for incident 
anemia.23 Similarly, previously results of the OCTABAIX 
cohort showed that mortality was higher among the group 
of patients with anemia, and this finding reached statisti-
cally significant differences after 3 years of follow-up.24 
In the present study, a new evaluation after 5 years of 
follow-up, showed that the association persisted but with 
less statistical power, and the signification was lost after the 
multivariate analysis.
Recent data evaluating the relationship between 
cholesterol and mortality in the oldest old pointed out a line 
Table 3 Adjusted multivariate Cox regression analysis model, 
with a backward-stepwise approach, of baseline variables 
associated or not to mortality of oldest old subjects after a 5-year 
follow-up
Hazard ratio 95% confidence 
interval
lawton index 0.856 0.781–0.914
Charlson index 1.199 1.082–1.330
Barthel index 0.997 0.986–1.009
spanish version of the 
Mini-Mental state examination
0.984 0.957–1.012
Mini nutritional Assessment 0.969 0.921–1.098
Tinetti gait scale 0.985 0.914–1.060
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Predictors of 5-year mortality in the oldest old
of thinking that could explain some of the results found in 
our present study. Conversely as it occurs in younger people, 
it has been suggested that low levels of total cholesterol – 
and even lower LDL cholesterol – might determine a worse 
prognosis in very old people, while high concentrations of 
HDL would be protective as it is in normal populations.25,26 
Thus, in our case, the contradictory results found may justify 
the loss of statistical significance.
Even though it has been found in several studies in elderly 
people aged 85 years or older,3 hypovitaminosis D – which 
was showen in more than a half of our participants aged 
85 years at baseline27 – was not able by itself to demonstrate 
association with mortality at either 3 years,19 nor at 5 years 
of follow-up. Moreover, an inverted CD4:CD8 ratio as an 
immune risk phenotype has been correlated with survival 
rates in elderly people;28 however, after 5 years of follow-up, 
these results could not be confirmed in our cohort of elderly 
community residents, as it had also not been shown during the 
first 3 years of follow-up.17 Finally, even it has been reported 
as an association between low thyroid function (high levels 
of thyrotropin) and longevity,29 it could not be demonstrated 
in our 85-year-old inhabitants in whom the thyroid function 
was normal at baseline in majority of the cases.20
Limitations
There are some limitations that have to be considered: first, 
despite the study being an extremely homogeneous study 
sample of subjects, its size was relative small, a fact that 
makes difficult the extension and generalization of the results 
showen; second, geriatric measurements were taken at base-
line, so it remains unknown whether periodic performance 
of geriatric assessment and/or laboratory tests throughout 
the age-decline follow-up might better predict mortality, 
also keeping in mind that the laboratory test included were 
analyzed individually and not grouped to build a score;30 and 
finally, the analysis did not take into account the impact of 
possible beneficial or harmful external interventions applied 
during the 5-year follow-up, such as those related to the 
caregivers’ support given to subjects for preventing falls and 
malnutrition, or the occurrence of adverse events related to 
hospital admission episodes.
Conclusion
In conclusion, even 5 years later, the present study reaffirmed 
the clinical value of a comprehensive geriatric assessment 
performed in elderly community residents. In the difficult 
step to reach from 85 to 90 years (four out of ten do not get 
there), a better ability to perform instrumental ADL and 
the presence of a less number of comorbidity conditions at 
baseline are the predictors for 5-year mortality identified 
in oldest old community-dwelling subjects aged 85 years, 
instead of the individual measurement of usual laboratory 
tests classically associated with death.
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